arrow
V

Veronica Steri

university of california
H指数:22
被引数:2,931

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A design approach for bitopic kinase inhibitors

双位点激酶抑制剂的构效关系设计方法

Nature
IF48.5
2026-09-230
OAAI
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer

自噬溶酶体胞吐作用将Src激酶反转到癌症的细胞表面

Science
IF45.8
2026-03-120
PRE
Selective treatment of acute myeloid leukemia targeting the activated conformation of integrin beta2 with [225Ac]Macropa-PEG4-7065

通过[225Ac]Macropa-PEG4-7065靶向整合素β2的活化构象,对急性髓系白血病进行选择性治疗

2025-11-100
PRE
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

靶向高风险多发性骨髓瘤基因型,采用优化的抗CD70 CAR T细胞

Blood
IF23.1
2025-05-150
OA
CDK8 Inhibition Represses Monocyte-like Gene Expression in Acute Myeloid Leukemia Cells and Antagonizes In Vivo Resistance to FLT3 Inhibition

CDK8 抑制在急性髓系白血病细胞中抑制单核细胞样基因表达,并拮抗体内对 FLT3 抑制的抵抗

BLOOD
IF23.1
2024-11-050
PRE
PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer
2024-09-271
OAAI
Targeting CDK1/2-driven mechanisms of resistance to BRAF and EGFR inhibition in BRAF(V600E) colorectal cancer restores therapeutic response
2024-03-220
PRE
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
2023-10-304
OAAI
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
2022-11-0924
OA
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma
2022-08-0113
OAAI